Αναζήτηση | La Lingua Nostra

πρόσθεσε ένα νέο άρθρο άλλο

2026-03-25 12:36:17 -

Global Ustekinumab Biosimilars Market Forecast 2026–2034: Growing at 8.7% CAGR to Reach USD 3.2 Billion

According to a new report from Intel Market Research, the global Ustekinumab Biosimilars market was valued at USD 1.5 billion in 2025 and is projected to reach USD 3.2 billion by 2034, growing at a CAGR of 8.7% during the forecast period (2026–2034). This substantial growth reflects increasing demand for cost-effective biologic alternatives to treat autoimmune disorders like psoriasis,...

0 Σχόλια 0 Μοιράστηκε 11 Views 0 Προεπισκόπηση